TVRD(Tvardi Therapeutics, Inc.) · 财务报表

TVRD(Tvardi Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2020-12-31FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31
营业收入$135.08M$23.03M$41.87M$20.97M$7.14M
毛利润—$23.03M———
营业利润$5.38M−$89.08M−$87.53M−$121.50M−$28.11M
净利润$8.41M−$88.44M−$85.47M−$118.51M−$29.40M
经营现金流−$5.49M−$60.09M−$78.73M−$92.08M−$18.30M
自由现金流−$5.84M−$60.13M−$78.77M−$94.45M−$19.35M
摊薄每股收益$6.48$-62.64$-57.36$-78.78$-11.42

Tvardi Therapeutics, Inc. TVRD